Old Web
English
Sign In
Acemap
>
authorDetail
>
Sandra J. Holmes
Sandra J. Holmes
Novartis
Virology
Immunology
Immunogenicity
Influenza vaccine
Vaccination
4
Papers
184
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A dose-ranging study of MF59®-adjuvanted and non-adjuvanted A/H1N1 pandemic influenza vaccine in young to middle-aged and older adult populations to assess safety, immunogenicity, and antibody persistence one year after vaccination
2014
Human Vaccines & Immunotherapeutics
Keith S. Reisinger
Sandra J. Holmes
Paola Pedotti
Ashwani Kumar Arora
Maria Lattanzi
Show All
Source
Cite
Save
Citations (16)
Clinical Efficacy of Cell Culture—Derived and Egg-Derived Inactivated Subunit Influenza Vaccines in Healthy Adults
2010
Clinical Infectious Diseases
Sharon E. Frey
Timo Vesikari
Agnieszka Szymczakiewicz-Multanowska
Maria Lattanzi
Allen Izu
Nicola Groth
Sandra J. Holmes
Show All
Source
Cite
Save
Citations (111)
Associations of the correlates of protection and implication on the statistical power for demonstrating non-inferiority: application of a re-sampling method on a large phase III influenza vaccine clinical trial.
2010
Vaccine
Roberto Bugarini
Daniela Casula
Nicola Groth
Maria Lattanzi
Sandra J. Holmes
Audino Podda
Show All
Source
Cite
Save
Citations (0)
Subunit Influenza Vaccines Produced from Cell Culture or in Embryonated Chicken Eggs: Comparison of Safety, Reactogenicity, and Immunogenicity
2009
The Journal of Infectious Diseases
Keith S. Reisinger
Stanley L. Block
Allen Izu
Nicola Groth
Sandra J. Holmes
Show All
Source
Cite
Save
Citations (57)
1